KEYTRUDA® (pembrolizumab) in metastatic non-small cell lung cancer (NSCLC) training and resources

Prescribing Information [External link]

KEYTRUDA® plus chemotherapy

KEYTRUDA® monotherapy

KEYTRUDA® in early stage NSCLC

Patient management

Supporting documentation

Prescribing Information [External link]
By clicking the link above you will leave the MSD Connect website and be taken to the emc PI portal website.